LeMaitre Vascular, Inc.

LMAT ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $50.9M
Cost of Revenue $13.6M
Gross Profit $37.3M
Gross Margin 73.3%
Operating Expenses
Research & Development $5.9M
SG&A Expense $9.9M
Operating Income $1.9M
Operating Margin 3.8%
Interest Expense $26.0K
Pretax Income $2.2M
Income Tax Expense $617.0K
Net Income $1.6M
Net Margin 3.1%
EPS (Basic) $0.10
EPS (Diluted) $0.10
Shares Outstanding (Basic) 15.7M
Shares Outstanding (Diluted) 15.9M
Dividends Per Share —
← Newer Page 3 of 3 Older →